Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
60.02 USD | -0.95% | +0.99% | -28.19% |
05-17 | Cytokinetics, Incorporated Announces Resignation of Sandford D. Smith as Board of Directors | CI |
05-15 | Transcript : Cytokinetics, Incorporated - Shareholder/Analyst Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.19% | 6.35B | |
+8.42% | 115B | |
+13.01% | 107B | |
-13.75% | 22.31B | |
-3.73% | 21.6B | |
-6.00% | 18.23B | |
-39.93% | 17.62B | |
+7.57% | 14.26B | |
+33.85% | 12.37B | |
-27.36% | 8.28B |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- JPMorgan Chase Adjusts Price Target on Cytokinetics to $52 From $55, Maintains Overweight Rating